Press Releases

ST. LOUIS, March 3, 2020 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its updated 2020 financial guidance, incorporating the effect of the closing of the WellCare acquisition on January 23, 2020. Total revenues are expected to be $104.8 billion to $105.6 billion, and diluted earnings per

CHICAGO, March 3, 2020 /PRNewswire/ -- The Illinois Homecare and Hospice Council (IHHC) has recognized Axxess for its industry leadership by awarding it the Council's 2020 Business Partnership Award. Axxess, the leading technology innovator for healthcare at home, received the award during the IHHC's annual conference.

CUPERTINO, Calif., March 3, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months and year

TARRYTOWN, N.Y., March 3, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:J.P. Morgan 2020 Biotech Conference Call Series at 12:00 p.m. ET on Friday, March 6, 2020 Oppenheimer 30th Annual Healthcare Conference at 8:35

WALTHAM, Mass., March 3, 2020 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today reported its financial results for the fourth quarter ended December 31, 2019. In addition, the Company provi

SAN DIEGO, March 3, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) will hold a webcast and conference call to discuss the Company's financial results and business highlights for the fourth quarter and year ended December 31, 2019.

MADISON, Wis. and PHOENIX, March 3, 2020 /PRNewswire/ -- (NASDAQ: EXAS) – Exact Sciences Corp. today announced the completion of its acquisitions of Paradigm Diagnostics, Inc. and Viomics, Inc., two privately held companies based in Phoenix. Together, Paradigm and Viomics provide a differe

STATESVILLE, N.C., March 3, 2020 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its third quarter of fiscal year 2020, ended January 31, 2020.

SAN FRANCISCO, March 3, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will release its fourth quarter and year-end 2019 financial results on March 16, 2020, after the market close. The Company will host a conference call at

SAN JOSE, Calif., March 3, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three months and year ended December 31, 2019. "Earlier recognition of vascular